Cargando…

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

Despite the advent of long-acting anti-retroviral therapy able to control and prevent infection, a preventative vaccine remains a global priority for the elimination of HIV. The moderately protective RV144 vaccine trial suggested functional IgG1 and IgG3 antibodies were a potential correlate of prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischinger, Stephanie, Cizmeci, Deniz, Deng, Davy, Grant, Shannon P., Frahm, Nicole, McElrath, Julie, Fuchs, Jonathan, Bart, Pierre-Alexandre, Pantaleo, Giuseppe, Keefer, Michael, O. Hahn, William, Rouphael, Nadine, Churchyard, Gavin, Moodie, Zoe, Donastorg, Yeycy, Streeck, Hendrik, Alter, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659322/ https://www.ncbi.nlm.nih.gov/pubmed/34843602 http://dx.doi.org/10.1371/journal.ppat.1010016

Ejemplares similares

Sex differences in vaccine-induced humoral immunity
por: Fischinger, Stephanie, et al.
Publicado: (2018)

Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19
por: Kaplonek, Paulina, et al.
Publicado: (2023)

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
por: Kaplonek, Paulina, et al.
Publicado: (2022)

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study
por: Huang, Yunda, et al.
Publicado: (2014)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination
por: Roy, Vicky, et al.
Publicado: (2023)

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis
por: Fischinger, Stephanie, et al.
Publicado: (2021)

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
por: Kaplonek, Paulina, et al.
Publicado: (2022)

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
por: Fischinger, Stephanie, et al.
Publicado: (2020)

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells
por: Fisher, Leigh, et al.
Publicado: (2019)

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
por: Bowman, Kathryn A., et al.
Publicado: (2022)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
por: Goepfert, P, et al.
Publicado: (2012)

Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials
por: Fiore-Gartland, Andrew, et al.
Publicado: (2016)

A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation()
por: Fischinger, Stephanie, et al.
Publicado: (2019)

The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design
por: Britto, Carl, et al.
Publicado: (2022)

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
por: Peiperl, Laurence, et al.
Publicado: (2010)

Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
por: Loos, Carolin, et al.
Publicado: (2023)

Abriendo Puertas: Baseline Findings from an Integrated Intervention to Promote Prevention, Treatment and Care among FSW Living with HIV in the Dominican Republic
por: Donastorg, Yeycy, et al.
Publicado: (2014)

The Antibodiome—Mapping the Humoral Immune Response to HIV
por: Butler, Audrey L., et al.
Publicado: (2019)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
por: Pušnik, Jernej, et al.
Publicado: (2022)

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials
por: Huang, Yunda, et al.
Publicado: (2015)

Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
por: Kaplonek, Paulina, et al.
Publicado: (2021)

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
por: Zhao, Lue Ping, et al.
Publicado: (2020)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

COVID-19 vaccination and HIV-1 acquisition – Authors’ reply
por: Buchbinder, Susan P, et al.
Publicado: (2022)

Use of adenovirus type-5 vectored vaccines: a cautionary tale
por: Buchbinder, Susan P, et al.
Publicado: (2020)

Factors related to fertility desire among female sex workers living with HIV in the Dominican Republic
por: Cernigliaro, Dana, et al.
Publicado: (2018)

Patient-provider communication about pregnancy and HIV among female sex workers living with HIV in Santo Domingo, Dominican Republic
por: Cernigliaro, Dana, et al.
Publicado: (2019)

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?
por: Self, S, et al.
Publicado: (2009)

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial
por: Mpofu, Rephaim, et al.
Publicado: (2021)

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
por: Pušnik, Jernej, et al.
Publicado: (2023)

Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination
por: Nduati, Eunice W., et al.
Publicado: (2021)

IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold miners
por: Davies, Leela R.L., et al.
Publicado: (2023)

Systems serology: profiling vaccine induced humoral immunity against HIV
por: Chung, Amy W., et al.
Publicado: (2017)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
por: Ditse, Zanele, et al.
Publicado: (2020)

Antibody glycosylation in inflammation, disease and vaccination
por: Alter, Galit, et al.
Publicado: (2018)

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
por: Churchyard, Gavin J., et al.
Publicado: (2011)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
por: Boudreau, Carolyn M., et al.
Publicado: (2019)

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
por: Janes, Holly, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tqekofvr877k33nf9q3oim1efs